Glenmede Trust’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-3,372
Closed -$459K – 2554
2020
Q3
$459K Buy
3,372
+1,385
+70% +$147K ﹤0.01% 810
2020
Q2
$191K Buy
+1,987
New +$166K ﹤0.01% 1025

Glenmede Trust's MYOK Position: Q4 2020 in Review

Glenmede Trust sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 3,372 shares — an estimated $459K sold.

Glenmede Trust first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $459K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Glenmede Trust reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 3,372 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $459K.
  • Glenmede Trust first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Glenmede Trust's MyoKardia, Inc. Common Stock position peaked at $459K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.